188 related articles for article (PubMed ID: 12113133)
1. Extranodal lymphoma of MALT-type: perspective at the beginning of the 21st century.
Raderer M; Isaacson PG
Expert Rev Anticancer Ther; 2001 Jun; 1(1):53-64. PubMed ID: 12113133
[TBL] [Abstract][Full Text] [Related]
2. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
[TBL] [Abstract][Full Text] [Related]
3. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
4. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of gastric lymphoma after stomach conserving treatment.
Fischbach W
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110
[TBL] [Abstract][Full Text] [Related]
6. Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Microsc Res Tech; 2000 Mar; 48(6):349-56. PubMed ID: 10738316
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
9. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.
Wündisch T; Kim TD; Thiede C; Morgner A; Alpen B; Stolte M; Neubauer A
Ann Hematol; 2003 Sep; 82(9):535-45. PubMed ID: 12845479
[TBL] [Abstract][Full Text] [Related]
10. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
[TBL] [Abstract][Full Text] [Related]
12. Gastric mucosa-associated lymphoid tissue lymphoma.
Ahmad A; Govil Y; Frank BB
Am J Gastroenterol; 2003 May; 98(5):975-86. PubMed ID: 12809817
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori, gastric MALT lymphoma, and adenocarcinoma of the stomach.
Go MF; Smoot DT
Semin Gastrointest Dis; 2000 Jul; 11(3):134-41. PubMed ID: 10950459
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori strikes again: gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Swisher SC; Barbati AJ
Gastroenterol Nurs; 2007; 30(5):348-54; quiz 355-6. PubMed ID: 18049205
[TBL] [Abstract][Full Text] [Related]
17. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
Ruskoné-Fourmestraux A; Fischbach W; Aleman BM; Boot H; Du MQ; Megraud F; Montalban C; Raderer M; Savio A; Wotherspoon A;
Gut; 2011 Jun; 60(6):747-58. PubMed ID: 21317175
[TBL] [Abstract][Full Text] [Related]
18. [The gastric MALT lymphoma. An unforeseen model for studying the pathogenesis of the lymphomas].
Savio A
Recenti Prog Med; 2009 Jun; 100(6):311-21. PubMed ID: 19708303
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of magnified endoscopic images of gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue, including changes after treatment.
Ono S; Kato M; Ono Y; Itoh T; Kubota K; Nakagawa M; Shimizu Y; Asaka M
Gastrointest Endosc; 2008 Oct; 68(4):624-31. PubMed ID: 18534580
[TBL] [Abstract][Full Text] [Related]
20. Mucosa-associated lymphoid tissue (MALT) lymphoma.
Manson SD
Semin Oncol Nurs; 2006 May; 22(2):73-9. PubMed ID: 16720229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
